Clinical Trials in Tennessee

Showing 201-220 of 9,675 trials

A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

NCT06660290

The purpose of this study is to evaluate the percentage of ocular adverse events reported in subjects with dry eye disease (DED) between the intervention arm (0.003% AR-15512) and control arm (REFRESH® Classic).

Dry Eye Disease

Alcon Research55 participantsStarted Jan 2025

Newport Beach, California, United States • Colorado Springs, Colorado, United States • Andover, Massachusetts, United States +3 more locations

RECRUITINGNA29 miles

ELEVATE High-Risk PCI Pivotal Study

NCT07001332

The ELEVATE III Pivotal Study is a prospective, multi-center, open-label, interventional, randomized, controlled study with an active control group. The study is intended to assess the safety and efficacy of the Elevate™ percutaneous Left Ventricular Assist Device System in patients referred to high-risk percutaneous coronary interventions (HR-PCI).

High-Risk Percutaneous Coronary Intervention (High-risk PCI)

Magenta Medical Ltd.290 participantsStarted Jul 2025

Scottsdale, Arizona, United States • San Francisco, California, United States • Tampa, Florida, United States +25 more locations

A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

ELEVATE High-Risk PCI Pivotal Study

Find Trials by Condition in Tennessee

[18F]F-DOPA Imaging in Patients With Autonomic Failure

PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

Empathic Communication Skills (ECS) Training

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

Donidalorsen Treatment in Children With Hereditary Angioedema

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

A Randomized, Active-Controlled, Double-Masked, Crossover Study to Evaluate the Clinical Performance of Deseyne (Vifilcon C) Daily Disposable Soft Contact Lens for Presbyopia Extended Depth of Focus (EDOF)

Actinium Therapy for Late-stage Aggressive Sarcomas

AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE